Jaguar Health, Inc.
JAGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3,083 | $2,979 | $2,214 | $3,509 |
| % Growth | 3.5% | 34.6% | -36.9% | – |
| Cost of Goods Sold | $1,092 | $527 | $515 | $557 |
| Gross Profit | $1,991 | $2,452 | $1,699 | $2,952 |
| % Margin | 64.6% | 82.3% | 76.7% | 84.1% |
| R&D Expenses | $3,658 | $3,265 | $3,730 | $4,534 |
| G&A Expenses | $0 | $6,160 | $6,150 | $5,033 |
| SG&A Expenses | $5,571 | $7,194 | $7,390 | $6,575 |
| Sales & Mktg Exp. | $0 | $1,034 | $1,240 | $1,542 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,229 | $10,459 | $11,120 | $11,109 |
| Operating Income | -$7,238 | -$8,007 | -$9,421 | -$8,157 |
| % Margin | -234.8% | -268.8% | -425.5% | -232.5% |
| Other Income/Exp. Net | -$2,410 | -$2,553 | -$1,175 | -$2,077 |
| Pre-Tax Income | -$9,648 | -$10,560 | -$10,596 | -$10,234 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9,502 | -$10,407 | -$10,464 | -$9,920 |
| % Margin | -308.2% | -349.3% | -472.6% | -282.7% |
| EPS | -6.28 | -10.26 | -16.7 | -33.68 |
| % Growth | 38.8% | 38.6% | 50.4% | – |
| EPS Diluted | -6.28 | -10.26 | -16.7 | -33.68 |
| Weighted Avg Shares Out | 1,513 | 1,015 | 627 | 295 |
| Weighted Avg Shares Out Dil | 1,513 | 1,015 | 627 | 295 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $15 | $56 | $110 |
| Interest Expense | $6 | $0 | $0 | $0 |
| Depreciation & Amortization | $560 | $556 | $546 | $593 |
| EBITDA | -$9,082 | -$7,451 | -$8,875 | -$15,753 |
| % Margin | -294.6% | -250.1% | -400.9% | -448.9% |